Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointments

18 Jun 2021 07:00

RNS Number : 3116C
CentralNic Group PLC
18 June 2021
 

18 June 2021

 

 

CentralNic Group plc

("CentralNic" or the "Company", or the "Group")

 

Board Appointments

 

CentralNic Group plc (AIM: CNIC), the global internet platform that derives revenue from the subscription sales of domain names and web services, announces the appointment to its board of Matthew Max Edward Royde ("Max Royde") and Horst Oskar Siffrin as Non-executive Directors with immediate effect. Max and Horst are joining the board as shareholder representatives of Kestrel Partners LLP and inter.services GmbH respectively.

 

Max Royde is currently managing partner at Kestrel Partners, an investment management company specialising in business-critical software companies, which has a beneficial holding in CentralNic of 56,583,670 shares or 22.53%. Max co-founded Kestrel Partners in 2009 and is a fund manager of Kestrel Opportunities. Prior to Kestrel Max was a managing director of KBC Peel Hunt, running its technology franchise. He has over 20 years' experience focusing on the technology sector.

Horst Siffrin started his career as a German diplomat serving in Germany, the UK, Ethiopia, Nigeria, Bolivia, Poland and Spain. He is partner of inter.services holding/investments, which has a beneficial holding in the Company of 37,085,870 shares or 14.77% and owner of H.O. Siffrin Consulting based in Berlin. From August 2011 until the reverse takeover of CentralNic in August 2018 he was Chairman of the Supervisory Board of KeyDrive SA, Luxemburg and member of the Advisory Board of the Key-Systems Group. In 2018 he co-founded AstraPharma.

Ben Crawford, CEO of CentralNic commented: "We are delighted to welcome Max to our board. Through Kestrel Partners he has been a long-term investor and supporter of CentralNic. He has extensive experience of UK listed technology companies and capital markets and his knowledge will be invaluable to us as we continue to grow the Company.

We also welcome Horst onto our board. Having held senior positions at our 2018 acquisition KeyDrive, Horst understands both our industry and our business and we look forward to his support in taking CentralNic to the next stage in its growth." 

The following disclosures are made in relation to paragraph (g) of Schedule Two of the AIM Rules for Companies:

 

Matthew Max Edward Royde (age 49)

 

Current Directorships

Past Directorships within the last 5 years

Kestrel Partners LLP

Kestrel Investment Partners LLP

Elms Road Capital Limited

Ingenta plc

Charles Connell & Company Holdings Limited

IDE Group Holdings plc

Track Record Holdings Limited

Gresham Technologies Plc

Trailight Ltd

 

Findlay Park Partners LLP

 

IQGeo Group plc

 

 

 

Max Royde was appointed as a director of Hotel Buyer Limited on 10 October 2000 and resigned on 10 May 2005. On 31 May 2005, the company passed an extraordinary resolution to put the company into creditors voluntary liquidation. The company was dissolved on 26 January 2008.

 

Horst Oskar Siffrin (age 73)

 

Current Directorships

Past Directorships within the last 5 years

inter.services GmbH

KeyDrive SA

H.O. Siffrin Consulting

 

AstraPharma GmbH

 

IIG - Invest in Growth GmbH

 

PerspektiveAfrika E.V

 

Seniorenhilfe.Saarland E.V

 

phi GmbH

 

Gastehaus Residenz Aurora - Horst Siffrin e.K

 

 

 

 

 

-Ends-

For further information:

CentralNic Group Plc

Ben Crawford, Chief Executive Officer

Don Baladasan, Group Managing Director

Michael Riedl, Chief Financial Officer

 

 +44 (0) 203 388 0600

Zeus Capital Limited (NOMAD and Joint Broker)

Nick Cowles / Jamie Peel (Corporate Finance)

John Goold / Rupert Woolfenden 

(Institutional Sales)

 

 

+44 (0) 161 831 1512

+44 (0) 203 829 5000

Stifel (Joint Broker)

Fred Walsh / Alex Price / Richard Short

+44 (0) 20 7710 7600

 

 

SEC Newgate (for Media)

Bob Huxford / Tom Carnegie / Isabelle Smurfit

+44 (0) 203 757 6880

centralnic@secnewgate.co.uk

 

 

About CentralNic Group plc 

CentralNic (AIM: CNIC) is a London-based AIM-listed company which drives the growth of the global digital economy by developing and managing software platforms allows businesses globally to buy subscriptions to domain names for websites and email, monetise domain names, and protect their brands online. Its core growth strategy is identifying and acquiring cash-generative businesses in its industry with annuity revenue streams and exposure to growth markets and migrating them onto the CentralNic software and operating platforms. 

CentralNic operates globally with customers in almost every country in the world. It earns recurring revenues from the worldwide sales of internet domain names and other services on an annual subscription basis. 

For more information please visit: www.centralnicgroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQPQUPGGMM
Date   Source Headline
25th Apr 20237:00 amRNSResult of AGM
24th Apr 20237:01 amRNSBoard Changes
24th Apr 20237:00 amRNSTrading Update
17th Apr 20237:00 amRNSDirectors' Dealings
17th Apr 20237:00 amRNSShare Awards and Exercise of Options
14th Apr 202311:01 amRNSDirectors' Dealings and Holdings in Company
11th Apr 20233:08 pmRNSDirectors' Dealings
5th Apr 20234:13 pmRNSDirectors' Dealings
3rd Apr 20237:00 amRNSDirectors' Dealings
30th Mar 20238:56 amRNSDirectors’ Dealings
27th Mar 20233:26 pmRNSDirectors’ Dealings
27th Mar 20237:00 amRNSAnnual Report, Notice of Q1 Update, AGM & Dividend
22nd Mar 20231:35 pmRNSDirectors’ Dealings
17th Mar 20234:00 pmRNSHolding(s) in Company
17th Mar 20237:00 amRNSDirectors’ Dealings
16th Mar 20237:00 amRNSHolding(s) in Company
14th Mar 20237:00 amRNSDirectors' Dealings
10th Mar 20237:15 amEQSCentralNic (CNIC): Clarifying the narrative
9th Mar 20237:00 amRNSDirectors’ Dealings
6th Mar 20237:00 amRNSDirectors' Dealings
2nd Mar 20237:00 amRNSCentralNic among FT's fastest growing in Europe
27th Feb 20237:00 amRNSUnaudited Preliminary Accounts for Full Year 2022
31st Jan 20237:00 amRNSPartnership Announcement
30th Jan 20237:00 amRNSTrading Update, Board Changes, Notice of Results
25th Jan 20238:08 amRNSDirectors' Dealings
23rd Jan 20237:00 amRNSDirector Dealings
20th Jan 20237:00 amRNSNotification of Major Holdings
20th Jan 20237:00 amRNSDirectors' Dealings
19th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSDirectors' Dealings
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20238:14 amRNSDirectors' Dealings
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSHolding(s) in Company
9th Jan 20234:17 pmRNSDirectors' Dealings
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20238:13 amRNSShare Awards and exercise of Options
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSDirectors' Dealings
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSShare Buyback Programme
21st Dec 20226:17 pmRNSDirectors' Dealings
19th Dec 20227:00 amRNSAcquisition Announcement
16th Dec 20225:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.